Mankind Pharma pledges additional stake in Bharat Serums and Vaccines to secure NCDs

Share it

The move relates to three debenture trust deeds executed on October 10, 2024, between Catalyst Trusteeship and Mankind Pharma.

Leave a Comment

Your email address will not be published. Required fields are marked *